Dr. Teresita Vázquez Appointed Director of City of Ruins Hospital

Leadership transitions at public hospitals often signal strategic shifts in community health priorities, particularly when they involve institutions serving historically underserved populations. The recent appointment of Dr. Teresita Vázquez as director of the Hospital de la “ciudad de las Ruinas” in Puerto Rico, replacing Dr. María Alejandra Pérez, arrives amid escalating concerns over dengue fever resurgence and strained primary care infrastructure across the island—a convergence of clinical require and administrative change that demands close scrutiny from both public health officials and frontline providers.

Key Clinical Takeaways:

• Puerto Rico reported over 1,200 dengue cases in Q1 2026, a 340% increase from the same period in 2025, driven by climate-induced Aedes aegypti proliferation and delayed vector control responses.
• Dr. Vázquez’s prior work in arbovirus surveillance positions her to strengthen hospital-based early detection systems, a critical gap identified in the 2025 PAHO dengue preparedness assessment.
• Effective outbreak response now hinges on integrating clinical diagnostics with municipal sanitation efforts—a systems-level challenge requiring coordinated action between healthcare providers and public health agencies.

The Hospital de la “ciudad de las Ruinas,” located in a high-morbidity zone for tropical infectious diseases, has long operated under resource constraints exacerbated by hurricane-related infrastructure damage and persistent nursing shortages. Dr. Vázquez, who previously led the Arbovirus Research Unit at the Ponce Health Sciences Institute, brings direct experience in managing dengue outbreaks through her leadership in a 2023 NIH-funded study (Grant R01AI152044) that evaluated point-of-care NS1 antigen testing in rural clinics—a strategy shown to reduce diagnostic delays by 62% in a cohort of 840 symptomatic patients across five municipalities. Her appointment suggests a potential pivot toward enhancing the hospital’s capacity for rapid febrile illness triage, a need underscored by the 2025 CDC Dengue Branch report highlighting that over 40% of severe dengue cases in Puerto Rico presented initially to facilities lacking adequate laboratory support.

Aligning Clinical Capacity with Epidemiological Reality

Under Dr. Pérez’s tenure, the hospital focused on expanding cardiac care services in response to rising hypertension-related mortality—a valid priority given that cardiovascular disease remains the island’s leading cause of death. However, the shifting epidemiology of arboviral threats, particularly dengue serotype 3’s reemergence after a two-decade absence, necessitates recalibration of surveillance and treatment protocols. As noted by Dr. Ángel Ruiz, epidemiologist at the University of Puerto Rico Graduate School of Public Health, “We’re seeing higher viral loads and earlier onset of plasma leakage in current dengue cases, which means hospitals must be ready to act within 24 hours of symptom onset—not 48 or 72.” This urgency is reflected in the updated 2024 WHO dengue management guidelines, which emphasize early fluid resuscitation and close hematocrit monitoring to prevent progression to severe disease.

“The real bottleneck isn’t always ICU beds—it’s the lag between fever onset and definitive diagnosis. Hospitals that can deploy rapid testing at triage save critical time in initiating protocol-driven care.”

This clinical imperative aligns with ongoing efforts to strengthen Puerto Rico’s public health laboratory network, including the CDC-funded Dengue Diagnostics Excellence Initiative, which has deployed PCR-capable instruments to six regional hospitals since 2023. Yet gaps persist in real-time data sharing between clinical sites and the Puerto Rico Department of Health’s surveillance system—a limitation Dr. Vázquez aims to address through proposed integration of the hospital’s electronic health records with the island’s MediTrack platform, a move supported by a 2024 Commonwealth-funded interoperability pilot.

Systems Thinking in Resource-Limited Settings

Beyond dengue, the hospital serves a population with high prevalence of diabetes and chronic kidney disease—comorbidities that significantly increase mortality risk during acute infections. Dr. Vázquez’s background in translational research includes work on biomarkers of endothelial dysfunction in diabetic patients during febrile illness, published in Diabetes Care in 2022. This expertise could prove valuable in refining risk stratification tools for hospitalized patients presenting with fever of unknown origin, potentially reducing unnecessary admissions while identifying those most likely to benefit from early intervention.

For clinicians navigating these complex diagnostic landscapes, access to specialized infectious disease consultation remains uneven. Patients presenting with persistent fever, thrombocytopenia, or elevated liver enzymes following potential mosquito exposure would benefit from timely evaluation by specialists familiar with tropical medicine protocols. Connecting with vetted infectious disease specialists through the World Today News Directory can facilitate timely second opinions or co-management strategies, particularly in cases where initial treatment fails to halt clinical deterioration.

Equally important is the role of environmental health in breaking transmission cycles. While clinical care manages individual cases, sustained reduction in dengue incidence requires robust vector control—an area where municipal sanitation departments and healthcare systems must collaborate. Facilities seeking to align their infection prevention strategies with community-level interventions may benefit from consulting public health consultants experienced in designing hospital-community partnership models for arbovirus prevention, a niche highlighted in recent PAHO technical guidance.

Finally, as hospitals like the one in “ciudad de las Ruinas” adapt to evolving infectious disease threats, ensuring regulatory compliance in emergency protocol updates and staff training becomes essential. Healthcare administrators overseeing these transitions often retain healthcare compliance attorneys to navigate reporting requirements under Puerto Rico’s Law 40 of 2020 on public health emergencies and to ensure alignment with CMS conditions of participation for Medicare-participating institutions.

The appointment of Dr. Vázquez represents more than a personnel change—it reflects an adaptive response to a dynamic threat landscape where clinical vigilance, diagnostic readiness, and intersectoral coordination determine outcomes. As climate patterns continue to alter the geographic and temporal boundaries of arboviral transmission, hospitals serving vulnerable populations must evolve from reactive treatment centers into nodes of early warning and rapid response. Success will depend not only on individual leadership but on the strength of the systems that support it—laboratories, data networks, specialist access, and community partnerships—all working in concert to turn epidemiological insight into lives saved.

*Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.*